CN106255758B - 病毒载体制造 - Google Patents

病毒载体制造 Download PDF

Info

Publication number
CN106255758B
CN106255758B CN201480071836.9A CN201480071836A CN106255758B CN 106255758 B CN106255758 B CN 106255758B CN 201480071836 A CN201480071836 A CN 201480071836A CN 106255758 B CN106255758 B CN 106255758B
Authority
CN
China
Prior art keywords
cells
cho
cell
virus
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201480071836.9A
Other languages
English (en)
Chinese (zh)
Other versions
CN106255758A (zh
Inventor
P·M·豪利
刘良
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Segmentis Ltd
Original Assignee
Segmentis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013904242A external-priority patent/AU2013904242A0/en
Application filed by Segmentis Ltd filed Critical Segmentis Ltd
Publication of CN106255758A publication Critical patent/CN106255758A/zh
Application granted granted Critical
Publication of CN106255758B publication Critical patent/CN106255758B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24151—Methods of production or purification of viral material
    • C12N2710/24152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN201480071836.9A 2013-11-01 2014-11-03 病毒载体制造 Active CN106255758B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2013904242A AU2013904242A0 (en) 2013-11-01 Viral vector manufacture
AU2013904242 2013-11-01
AU2014900370A AU2014900370A0 (en) 2014-02-07 Orthopox vectors and propagation
AU2014900370 2014-02-07
PCT/AU2014/050330 WO2015061858A1 (en) 2013-11-01 2014-11-03 Viral vector manufacture

Publications (2)

Publication Number Publication Date
CN106255758A CN106255758A (zh) 2016-12-21
CN106255758B true CN106255758B (zh) 2020-06-23

Family

ID=53003022

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480071836.9A Active CN106255758B (zh) 2013-11-01 2014-11-03 病毒载体制造

Country Status (24)

Country Link
US (2) US10544397B2 (enExample)
EP (2) EP3375882B1 (enExample)
JP (2) JP6682443B2 (enExample)
KR (1) KR102047030B1 (enExample)
CN (1) CN106255758B (enExample)
AU (1) AU2014344738B2 (enExample)
CA (1) CA2931518C (enExample)
CY (1) CY1121414T1 (enExample)
DK (2) DK3063278T3 (enExample)
ES (1) ES2670034T3 (enExample)
HR (1) HRP20180789T1 (enExample)
HU (1) HUE037718T2 (enExample)
LT (1) LT3063278T (enExample)
NO (1) NO3063278T3 (enExample)
NZ (1) NZ720241A (enExample)
PL (1) PL3063278T3 (enExample)
PT (1) PT3063278T (enExample)
RS (1) RS57290B1 (enExample)
RU (1) RU2658487C2 (enExample)
SG (1) SG11201603919XA (enExample)
SI (1) SI3063278T1 (enExample)
SM (1) SMT201800267T1 (enExample)
TR (1) TR201807128T4 (enExample)
WO (1) WO2015061858A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3265584A1 (en) * 2016-08-19 2025-03-14 Sementis Ltd VIRUS VACCINES
JP2018081568A (ja) * 2016-11-17 2018-05-24 グローリー株式会社 紙幣収納装置および紙幣処理機
CA3258751A1 (en) * 2022-06-30 2024-01-04 Bavarian Nordic As Mammalian cell line for the production of modified Ankara vaccine virus (MVA)
WO2024064608A2 (en) * 2022-09-20 2024-03-28 Intergalactic Therapeutics, Inc. Best1 vectors and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101541972A (zh) * 2006-08-04 2009-09-23 都柏林城市大学 生产重组生物产品的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2604183B1 (fr) * 1986-09-23 1988-12-30 Transgene Sa Sequence d'adn, vecteurs, virus recombinants et procede mettant en oeuvre des virus de la vaccine recombinants capables de se multiplier dans les cellules cho
EP0758397B1 (en) 1994-04-29 2005-06-22 Baxter Healthcare S.A. Recombinant poxviruses with foreign polynucleotides in essential regions
WO2004015118A1 (en) * 2002-08-07 2004-02-19 Bavarian Nordic A/S Vaccinia virus host range genes to increase the titer of avipoxviruses
FR2884255B1 (fr) * 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101541972A (zh) * 2006-08-04 2009-09-23 都柏林城市大学 生产重组生物产品的方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Complementation of a Vaccinia Virus Host-Range K1L Gene Deletion by the Nonhomologous CP77 Gene;ANNA L. RAMSEY-EWING, et al.;《VIROLOGY》;19960801;第222卷(第1期);第75页摘要，第78页左栏倒数第1段-右栏第2段 *
Immature Viral Envelope Formation Is interrupted at the Same Stage by lac Operator-Mediated Repression of the Vaccinia Virus D13L Gene and by the Drug Rifampicin;YIFAN ZHANG, et al.;《VIROLOGY》;19920430;第187卷(第2期);第652页左栏第2段 *

Also Published As

Publication number Publication date
JP2016534755A (ja) 2016-11-10
CA2931518A1 (en) 2015-05-07
HUE037718T2 (hu) 2018-09-28
EP3063278A4 (en) 2017-04-12
SI3063278T1 (sl) 2019-04-30
ES2670034T3 (es) 2018-05-29
RU2658487C2 (ru) 2018-06-21
SG11201603919XA (en) 2016-07-28
SMT201800267T1 (it) 2018-07-17
KR102047030B1 (ko) 2019-11-20
AU2014344738B2 (en) 2019-03-21
AU2014344738A1 (en) 2016-06-09
DK3375882T3 (da) 2019-12-16
EP3375882A1 (en) 2018-09-19
HK1223395A1 (en) 2017-07-28
RU2016121425A (ru) 2017-12-04
NZ720241A (en) 2019-10-25
LT3063278T (lt) 2018-07-10
PT3063278T (pt) 2018-05-25
JP2020039340A (ja) 2020-03-19
US20200190482A1 (en) 2020-06-18
CY1121414T1 (el) 2020-05-29
TR201807128T4 (tr) 2018-06-21
DK3063278T3 (en) 2018-06-06
CA2931518C (en) 2021-03-09
HRP20180789T1 (hr) 2018-09-07
EP3375882B1 (en) 2019-10-16
KR20160079868A (ko) 2016-07-06
NO3063278T3 (enExample) 2018-07-28
WO2015061858A1 (en) 2015-05-07
JP6682443B2 (ja) 2020-04-15
PL3063278T3 (pl) 2018-08-31
EP3063278A1 (en) 2016-09-07
EP3063278B1 (en) 2018-02-28
US20170029784A1 (en) 2017-02-02
RS57290B1 (sr) 2018-08-31
US10544397B2 (en) 2020-01-28
CN106255758A (zh) 2016-12-21

Similar Documents

Publication Publication Date Title
JP5783642B2 (ja) Ｍｖａの主なゲノム欠失を含むワクシニアウイルス変異体
TW202203966A (zh) 用於防範ｃｏｖｉｄ－１９之以減毒的痘病毒載體為底質之疫苗
JP2020039340A (ja) ウイルスベクターの作製
US20210113684A1 (en) Vector-based attenuated poxvirus vaccines
CN105039268A (zh) 表达鸭坦布苏病毒e蛋白的重组鸭瘟病毒及其构建方法和应用
HK1260426A1 (en) Viral vector manufacture
HK1260426B (en) Viral vector manufacture
WO2023066920A1 (en) Recombinant african swine fever virus and uses thereof
HK1223395B (en) Viral vector manufacture
RU2778312C2 (ru) Вирусные вакцины
Busha A Novel Selection Technology for the Discovery of High-Affinity Human Proteins

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP02 Change in the address of a patent holder
CP02 Change in the address of a patent holder

Address after: South Australia Australia

Patentee after: Sementis Ltd.

Address before: Victoria, Australia

Patentee before: Sementis Ltd.